A comparison between different postoperative treatment modalities of uterine carcinosarcoma-Reference-Cited by-同舟云学术

A comparison between different postoperative treatment modalities of uterine carcinosarcoma

Published:2005-04 Issue:1 Volume:97 Page:166-170
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Menczer Joseph,Levy Tally,Piura Benjamin,Chetrit Angela,Altaras Marco,Meirovitz Mihai,Glezerman Marek,Fishman Ami

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference42 articles.

1. The prognostic relevance of histological type in uterine sarcomas: a cooperation task force (CTF) multivariate analysis of 249 cases;Gadducci;Eur. J. Gynecol. Oncol.,2002

2. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A gynecologic oncology group pathologic study of 203 cases;Silverberg;Int. J. Gynecol. Pathol.,1990

3. Malignant mixed Mullerian tumor of the uterus. Feature favoring its origin from a common cell clone and an epithelial to mesenchimal transformation of histogenesis;Guarino;Tumori,1998

4. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas;McCluggage;Int. J. Gynecol. Cancer,2002

5. Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma;Abargel;Int. J. Gynecol. Cancer,2004

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Profile and Treatment Outcomes of Malignant Mixed Mullerian Tumors of the Uterus: A Single-Center Experience;Cureus;2023-10-31

2. Uterine carcinosarcoma: A 10-year single institution experience;PLOS ONE;2022-07-21

3. Evaluation of chemotherapy and radiotherapy in the adjuvant management of uterine carcinosarcoma: a population-based analysis;Archives of Gynecology and Obstetrics;2022-06-16

4. Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network;Cancers;2022-01-12

5. Adjuvant chemotherapy in patients with uterine carcinosarcoma: a review of clinical outcomes and considerations;Expert Opinion on Orphan Drugs;2021-12-02